30
Participants
Start Date
August 25, 2022
Primary Completion Date
July 18, 2028
Study Completion Date
July 18, 2028
Asfotase Alfa
All participants will receive asfotase alfa subcutaneously per standard of care. Unless otherwise specified per the Physician's standard of care, participants aged \< 2 years are recommended for a clinic visit approximately every 3 months after Enrollment until 2 years of age, after which they should have a clinic visit approximately every 6 months. Participants should be followed for 5 years, as possible.
RECRUITING
Clinical Trial Site, Mineola
NOT_YET_RECRUITING
Clinical Trial Site, Pittsburgh
RECRUITING
Clinical Trial Site, Charlottesville
RECRUITING
Clinical Trial Site, Nashville
RECRUITING
Clinical Trial Site, Columbus
NOT_YET_RECRUITING
Clinical Trial Site, Cincinnati
RECRUITING
Clinical Trial Site, Madison
RECRUITING
Clinical Trial Site, Chicago
RECRUITING
Clinical Trial Site, Kansas City
RECRUITING
Clinical Trial Site, Salt Lake City
RECRUITING
Clinical Trial Site, Hartford
RECRUITING
Clinical Trial Site, Boston
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY